Lyt til artiklen
A Danish company has developed a treatment for ischemic stroke which includes a chemical extracted from the saliva of a vampire bat.
The H. Lundbeck A/S pharmaceutical company says it has begun two clinical phase III trials, putting it close to releasing a revolutionary treatment for the disease which includes desmoteplase.
